A61K 33/28
Mercury
Official title: Mercury; Compounds thereof
A61K33/28 (Mercury) appears on 58 US grants and 62 published applications in this corpus.
Search patents in A61K- Granted patents
- 58
- Published applications
- 62
- Assignees
- 32
- Inventors
- 96
- Latest grant
- 10 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 1 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 1 | 4 |
| 2007 | 0 | 5 |
| 2008 | 0 | 3 |
| 2009 | 0 | 4 |
| 2010 | 1 | 3 |
| 2011 | 1 | 0 |
| 2012 | 1 | 3 |
| 2013 | 0 | 3 |
| 2014 | 1 | 1 |
| 2015 | 4 | 7 |
| 2016 | 4 | 5 |
| 2017 | 1 | 3 |
| 2018 | 2 | 1 |
| 2019 | 3 | 5 |
| 2020 | 4 | 3 |
| 2021 | 6 | 0 |
| 2022 | 5 | 5 |
| 2023 | 7 | 3 |
| 2024 | 3 | 1 |
| 2025 | 5 | 1 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Stable, highly pure L-cysteine compositions for injection and methods of use10 Mar 2026US 12,569,513 B1Exela Pharma Sciences, LLC
- Stable, highly pure L-cysteine compositions for injection and methods of use10 Mar 2026US 12,569,514 B1Exela Pharma Sciences, LLC
- Surgical recovery and maintenance of oral health2 Dec 2025US 12,485,155 B2StellaLife, Inc.
- Oral rinse for management of post-oral surgical recovery and maintenance of oral health12 Aug 2025US 12,383,594 B2StellaLife, Inc.
- Homeopathic complex5 Aug 2025US 12,377,145 B2
- Homeopathic complex18 Sep 2025US 2025/0288676 A1
- Inhibitors of sarm1 nadase activity and uses thereof18 Jul 2024US 2024/0238264 A1Disarm Therapeutics, Inc.
- Formulation for management of post-oral surgical recovery and maintenance of oral health2 Nov 2023US 2023/0346869 A1StellaLife, Inc.
- Use of electric current or field to manage risk of infection by antimicrobial-resistant microorganisms2 Nov 2023US 2023/0346995 A1The Trustees of Indiana University
- Oral rinse for management of post-oral surgical recovery and maintenance of oral health5 Oct 2023US 2023/0310535 A1StellaLife, Inc.
Most cited
By later US patents
- Sty ointment and method of using the same43US 4,612,193 ADel Laboratories, Inc. · 1986
- Method for coating particles in a spray-drying plant30US 5,487,916 A1996
- Stable, highly pure L-cysteine compositions for injection and methods of use21US 10,478,453 B1Exela Pharma Sciences, LLC · 2019
- Proteinase inhibitors for treatment of gastrointestinal ulcer disease17US 4,891,356 AThe Brigham and Women S Hospital, Inc. · 1990
- Stable, highly pure L-cysteine compositions for injection and methods of use15US 10,583,155 B1Exela Pharma Sciences, LLC · 2020